Director of the Oxford Center will be Academician Zhanfeng CUI who is also member of the Royal Academy of Engineering. China will provide £ 7,5 million funding to the Center over 5 years, which will also be used to fund 20 Ph. D. students at Oxford. Results will, through Oxford University’s ISIS technology transfer center, be outlicensed to China Bio-Med Regeneration Technology Ltd., for exploitation in China. Projects are centered on the use of stem cells to treat diabetes, cancer, neurodegenerative diseases and organ repair.

China Bio news release, Dec. 23, 2014